Table 4.
Variable | β | 95% CI | p value∗ | |
---|---|---|---|---|
Group | Placebo group | Reference | ||
ALC group | -1.18 | -0.52, -1.84 | 0.001 | |
Gender | Female | Reference | ||
Male | 0.38 | -0.17, 1.14 | 0.20 | |
Coronary artery diseases | No | Reference | ||
Yes | 0.65 | -0.12, 1.42 | 0.098 | |
mRS before | 0.87 | 0.49, 1.27 | <0.001 |
Note: ALC = acetyl-L-carnitine. ∗Adjusted for other variables in the model. The significant p value is shown in bold type.